[1] DANIEL B, HOSSEIN A, JUDY Q.Zolpidem[M] // StatPearls Treasure Island (FL): StatPearls Publishing; 2020. [2] JAIME MM, DAVID WS, KENNETH B, et al.Zolpidem’s use for insomnia[J]. Asian J Psychiatr, 2017, 25: 79-90. [3] CHIARO G, CASTEINOVO A, BIANCO G, et al.Severe chronic abuse of zolpidem in refractory insomnia[J]. J Clin Sleep Med, 2018, 14(7): 1257-1259. [4] LU L.Shen Yu Cun Psychiatry(沈渔邨精神病学)[M]. Beijing: People’s Medical Publishing House, 2018: 882-885. [5] WANG XH.The latest psychiatric medication(最新精神疾病用药)[M]. Beijing: People’s Military Medical Publishing House, 2010:304-307. [6] LIU HP.Chinese Medical Encyclopedia Clinical Medicine(中华医学百科全书临床医学)[M]. Beijing: China Union Medical College Press, 2019: 91-92. [7] DAVID JG, JEROLD SH, THOMAS R.Zolpidem and gender: are women really at risk?[J]. J Clin Psychopharmacol, 2019, 39(3): 189-199. [8] SUN T.Guidelines for rational use of common household medicines(家庭常用药物合理使用指南)[M]. Changchun: Jilin Science and Technology Press, 2016: 422-423. [9] American Geriatrics Society 2015 Beers Criteria Update Expert Panel, FICK DM, SEMLA TP, et al. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults[J]. J Am Geriatrics Society, 2015, 63(11): 2227-2246. [10] WEN JS.Analysis of the clinical effect of the treatment of depression with insomnia disorder by idebenone[D]. Shandong University, 2020. [11] SUN Y.Practical psychiatry diagnosis and treatment(实用精神科疾病诊疗学)[M]. Changchun:Jilin Science and Technology Press, 2019: 128. [12] SCHWAB S, SCHELLINGER, WERNER C, et al.Neurocritical Care Medicine[M]. Wuhan: Hubei Science and Technology Press, 2018: 342-343. [13] PANG Y, TANG LL.Principles of diagnosis and treatment of delirium in tumor patients[J]. Chinese Journal of Pain Medicine(中国疼痛医学杂志), 2012, 18(10): 586-589. [14] LI XH, CHEN HY, LIU M,et al.Observation and management of delirium in patients with advanced tumor[J]. Clinical and Rehabilitation of Oncology in China(中国肿瘤临床与康复), 2016(9): 1145-1147. [15] PELLAND C, TRUDEL JF.Atypical antipsychotic efficacy and safety in managing delirium: a systematic review and critical analysis[J]. Psychol Neuropsychiatr Vieil, 2009, 7(2): 109-119. [16] FONG TG, TULEBAEV SR, INOUYE SK.Delirium in elderly adults: diagnosis, prevention and treatment[J]. Nature Reviews Neurology, 2009, 5(4): 210-220. [17] DENG QE, LIU GW, ZHAO JX, et,al. Clinical efficacy of aripiprazole combined with lithium carbonate in the treatment of bipolar disorder in remission and its effect on cognitive function[J]. China Pharmaceuticals(中国药业), 2021, 30(1): 45-48. [18] WESTERMEYER J, CARR TM.Zolpidem-associated consequences: an updated literature review with case reports[J]. J Nerv Ment Dis, 2020, 208(1): 28-32. [19] XIONG FW, YU CL, BAI QJ, et, al. Chinese Clinical Medicine Dictionary on Chemical Medicine Volume[M]. Beijing: China Medical Science and Technology Press, 2018:1222-1223. [20] XU YZ, GUO CS, LU FZ.New fully practical drug manual(新全实用药物手册)[M]. Zhengzhou: Henan Science and Technology Press, 2018: 523. [21] FITZGERALD AC, WRIGHT BT, HELDt SA.The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors[J]. Psychopharmacology, 2014, 231(9): 1865-1896. [22] WEI TX, WEI JH.Medical Manual for Physicians(医生专用药物手册)[M]. Zhengzhou: Henan Science and Technology Press, 2015: 554-555. [23] JIMÉNEZ-GENCHI A, GRUPO DE ESTUDIO ZONIA. Efficacy and safety of modified release zolpidem in patients with chronic insomnia[J]. Rev Med Inst Mex Seguro Soc, 2012, 50(5): 529-36. [24] MACFARLANE J, MORIN CM, MONTPLAISIR J.Hypnotics in insomnia: the experience of zolpidem[J]. Clin Ther, 2014,36(11): 1676-701. [25] CHO CH, JEE HJ, NAM YJ, et al.Temporal association between zolpidem medication and the risk of suicide: a 12-year population-based, retrospective cohort study[J]. Sci Rep. 2020, 10(1): 4875. [26] TSAI MY, TSAI MH, YANG SC, et al.Transient global amnesia-like episode due to mistaken intake of zolpidem: drug safety concern in the elderly[J]. J Patient Saf, 2009, 5(1): 32-34. [27] YANG YH, XU XL, ZHU Z.Safety risks and key points of use of zolpidem tartrate[J]. Chinese Journal of Pharmaceuticals(中国药学杂志), 2019, 54(14):1188-1193. [28] YANG Y, CHEN Q, CHEN S, et al.Retrospective analysis of 29 cases of adverse reactions to zolpidem[J]. The World’s Latest Medical Information Digest(世界最新医学信息文摘), 2019, 19(43): 151-152. [29] MOORE TJ. MATTISON DR.Assessment of patterns of potentially unsafe use of zolpidem[J]. JAMA Intern Med, 2018, 178(9): 275-277. |